DCTH (Delcath Corp) Yalpi marja

Delcath (DCTH) korporativ emblemasi va logotipi

Zaxira rezervlari hisobiga ta'minlangan uzluksiz tizim yig'ish jarayoni Delcath Systems, Inc. (DCTH) kompaniyasining joriy yalpi foyda darajalarida aks etgan barqarorlikni qo'llab-quvvatlamoqda. Daromadlar uskunalar va ximioterapiya uchun bir marta ishlatiladigan to'plamlarning sotuviga asoslangan, onkologiya markazlarida protokollarning joriy etilishi esa doimiy talabni ta'minlaydi. 87.60 qiymati ushbu moliyaviy ko'rsatkichning joriy miqdorini ko'rsatib, Delcath Systems, Inc. (DCTH) operatsion modelining samaradorligini tasdiqlaydi.

delcath.com (DCTH) - Yalpi marja 04.07.2022dan 19.11.2026gacha

delcath.com (DCTH) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti

Kompaniyaning jamlanma tahlili:DCTH Delcath Systems Inc
Delcath Systems, Inc. tomonidan chiqariladigan mahsulotlar

Noyob jigar xemioperfuziya tizimlari bo'yicha ixtisoslashgan medtexnologiya sektori uchun yalpi foyda intellektual mulkni monetizatsiya qilish va bozor nishasini himoya qilish samaradorligining asosiy ko'rsatkichi bo'lib xizmat qiladi. Ushbu metrika tushum va sotilgan tovarlar tannarxi orasidagi farqning umumiy savdoga nisbati sifatida hisoblanadi; tarixiy yalpi foydani tahlil qilish orqali investor Delcath Systems, Inc. (DCTH) kompaniyasining patent himoyasi va FDA tasdig'i orqali muolajalarning yuqori daromadliligini saqlab qolish qobiliyatini baholaydi.

Asosiy raqobatchilar

Yalpi foyda marjasi BeiGene Ltd. (ONC)|Yalpi foyda bo'yicha rentabellik HALO|Yalpi rentabellik RVMD|Yalpi foyda bo'yicha rentabellik AAPG (Ascentage)|Yalpi foyda bo'yicha rentabellik cgoncology.com CGON|UroGen Pharma - Yalpi foyda bo'yicha rentabellik|Yalpi foyda normasi BCAX|PSNL - Yalpi rentabellik|Yalpi foyda bo'yicha sotuv rentabelligi Erasca Oncology ERAS|YMAB: Yalpi marja|AURA - Yalpi foyda bo'yicha sotuv rentabelligi|CADL (Candel Therapeutics Inc.) - Yalpi marja|Sotuvning yalpi rentabelligi ARAY (Accuray)|Yalpi foyda bo'yicha rentabellik SLS (SELLAS Life Sciences Group, Inc.)|ACTU - Yalpi foyda marjasi|Yalpi rentabellik Citius Oncology, Inc. CTOR|HURA - Yalpi foyda bo'yicha rentabellik|protaratx.com - Yalpi marja|FATE - Yalpi marja|WHWK: Yalpi marja|TScan Therapeutics (TCRX) - Yalpi marja|Yalpi rentabellik Champions Oncology|Yalpi rentabellik XBIT|Yalpi marja CVM|Yalpi foyda bo'yicha rentabellik OS Therapies Inc. OSTX|Yalpi rentabellik Radiopharm Theranostics Limited RADX|artivabio.com (ARTV) - Yalpi foyda marjasi|ANL - Yalpi rentabellik|Yalpi foyda marjasi verupharma.com|TPST: Yalpi marja|XLO - Yalpi foyda bo'yicha sotuv rentabelligi|Yalpi rentabellik Renovaro|Yalpi marja muraloncology.com|Yalpi marja KAPA|Yalpi foyda bo'yicha sotuv rentabelligi OnKure Therapeutics, Inc.|Yalpi marja GDTC (w2.cytomed.sg)|CRIS - Yalpi foyda bo'yicha rentabellik|Apollomics - Yalpi marja|Tharimmune Corp (THAR) - Yalpi foyda bo'yicha rentabellik|ADVB: Yalpi marja|Yalpi foyda bo'yicha rentabellik Genprex|CLDI (Calidi Biotherapeutics, Inc.) - Yalpi marja|Sotuvning yalpi rentabelligi SBFM (Sunshine Biopharma)|Yalpi rentabellik Xenetic Bio (XBIO)|Yalpi rentabellik SLRX (Salarius Pharma)|Kitov Pharma - Yalpi foyda bo'yicha rentabellik|American Oncology Network (AONC) - Yalpi foyda marjasi|BeiGene - Yalpi marja|Checkpoint Therapeutics, Inc. (CKPT) - Yalpi foyda bo'yicha rentabellik|ELEV (Elevation Oncology, Inc.) - Yalpi foyda bo'yicha rentabellik|iCAD Inc. - Yalpi foyda normasi|Yalpi foyda bo'yicha rentabellik IKNA|Yalpi marja notablelabs.com|Yalpi foyda bo'yicha rentabellik VIRX (Viracta Therapeutics Inc.)|MOR - Yalpi foyda marjasi|Yalpi rentabellik NAYA Biosciences NAYA|AAPGV - Yalpi foyda bo'yicha rentabellik